Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Talaris Therapeutics, Inc.
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 10-Q | | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Assets |
| Cash and equivalents | 18.4 | | 25.5 | 22.8 | 18.6 | 27.3 | 36.3 | 9.9 |
| Short-term investments | | | | | | 227.4 | 229.9 | 130.2 |
| Other current assets | 137.9 | | 186.5 | 205.6 | 227.9 | 3.5 | 4.3 | 2.7 |
| Total current assets | 156.2 | | 212.0 | 228.4 | 246.5 | 258.2 | 270.5 | 142.8 |
| Property, plant, and equipment, net | 0.2 | | 5.7 | 5.5 | 4.8 | 3.0 | 2.3 | 2.1 |
| Long-term investments | 1.5 | | | | | | | |
| Other fixed assets | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Total assets | 159.1 | | 220.9 | 237.2 | 251.4 | 261.3 | 272.8 | 144.9 |
| |
| Accounts payable | 2.9 | | 2.1 | 3.5 | 2.6 | 1.2 | 1.3 | 0.8 |
| Accrued expenses | | | | | | 3.8 | 3.4 | 2.8 |
| Short-term debt | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 7.2 | | 5.3 | 4.6 | 5.4 | | | |
| Total current liabilities | 10.1 | | 7.3 | 8.1 | 8.0 | 5.0 | 4.7 | 3.6 |
| Other liabilities | 0.6 | | 2.8 | 3.2 | 0.6 | 0.7 | 0.8 | 1.6 |
| Total liabilities | 10.7 | | 10.2 | 11.2 | 8.6 | 5.7 | 5.5 | 5.2 |
| |
| Shareholders' equity [+] | 148.4 | | 210.7 | 226.0 | 242.8 | 255.6 | 267.4 | 139.7 |
| Paid-in capital | 350.6 | | 339.1 | 336.1 | 333.7 | 332.2 | 331.0 | 5.8 |
| Retained earnings | -202.0 | | -127.2 | -109.1 | -90.8 | -76.6 | -63.7 | -52.3 |
| Tangible shareholders' equity | 148.4 | | 210.7 | 226.0 | 242.8 | 255.6 | 267.4 | 139.7 |
|